16 小时
Zacks Investment Research on MSNModerna Q4 Earnings and Revenues Beat, COVID Vaccine Sales DeclineModerna MRNA incurred a loss of $2.50 per share in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of ...
Human uptake of microplastic particles (MPs) is causing increasing health concerns, and there is mounting pressure to evaluate the associated risks. While MPs can be ingested, breathed in, or drank in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果